Durable complete response of advanced hepatocellular carcinoma using cannabis oil. A report of two cases.

Background. Hepatocellular carcinoma (HCC) is a leading cause of cancer-related mortality worldwide with a grim prognosis. Current treatment options for advanced HCC are limited, and a large proportion of patients is not amenable to any form of treatment, with best supportive care as the only remaining option. Meanwhile, the use of cannabis-derived products is rising in oncological patients who are seeking symptom relief. Cannabinoids, similar to endogenous endocannabinoids, have shown promise in recent preclinical cancer research due to their ability to interact with various signaling pathways and molecular mechanisms of interest. Case presentation. In this report, we present two patients with advanced HCC with a high tumor burden who demonstrated durable and complete regression after use of cannabis oil for symptom relief. The observations in this report build on previous (pre)clinical research highlighting the potential anti-tumor qualities of cannabinoids and stress the need for clinical trials investigating the anti-tumor effects of cannabinoids in cancer patients. Conclusion. Based on the two cases presented here, we call for further research into the potential beneficial effect of cannabinoids in patients with advanced HCC.